|
EQS-News: Alzchem Group AG
/ Key word(s): Share Buyback
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Share Repurchase
Alzchem Group AG announces the start of the share repurchase program which was published by an ad hoc announcement dated November 5, 2024.
Starting December 2, 2024, Alzchem Group AG (hereinafter also referred to as the “Company”) will repurchase over a period of up to twelve months up to 100,000 no-par-value shares of the Company having a total purchase price of up to EUR 6 million (excluding ancillary purchase costs) exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA). The maximum purchase price per share (excluding ancillary purchase costs) will not exceed the share price determined by the opening auction in XETRA trading on the trading day by more than 10 per cent and it will not fall short of the share price by more than 20 per cent. The Managing Board of Alzchem Group AG, upon authorization of the Supervisory Board, is thus exercising the authorization by the Annual General Meeting on May 7, 2024, to acquire own shares.
The purpose of the buyback is (i) to acquire an acquisition currency, (ii) to issue the repurchased shares to employees of Alzchem Group or (iii) to redeem the shares. Other legally permissible purposes covered by the authorization of the Annual General Meeting are not excluded.
The repurchase program will be carried out on behalf and account of Alzchem Group AG through a bank, which was commissioned by the Company. The bank will decide on the timing of the share purchase independently and without being influenced by the Company. The share repurchase program may be suspended and resumed at any time, in line with applicable statutory regulations.
Regardless of the extended purposes the share repurchase program will be implemented pursuant to the trading terms of Art. 5 of the EU Regulation no 596/2014 and Art. 2 Sec. (1) of the Delegated EU Regulation no 2016/1052 (“DelReg”). Accordingly, executed repurchases will be announced in a manner compliant with the requirements of Art. 2 Sec. (3) DelReg no later than on the seventh trading day following their conclusion. In addition, Alzchem Group AG will provide regular updates on the progress of the share repurchase program at www.alzchem.com.
Trostberg, November 29, 2024
Alzchem Group AG - Managing Board -
29.11.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Alzchem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 2041541 |
| End of News | EQS News Service |
|
|
2041541 29.11.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
